Heavy mutagenesis by tobacco leads to lung adenocarcinoma tumors with KRAS G12 mutations other than G12D, leading KRAS G12D tumors—on average—to exhibit a lower mutation burden-Reference-Cited by-同舟云学术

Heavy mutagenesis by tobacco leads to lung adenocarcinoma tumors with KRAS G12 mutations other than G12D, leading KRAS G12D tumors—on average—to exhibit a lower mutation burden

Published:2021-10 Issue: Volume: Page:
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tan Chichun,Mandell Jeffrey D.,Dasari Krishna,Cannataro Vincent L.,Alfaro-Murillo Jorge A.,Townsend Jeffrey P.

Funder

National Institute of Dental and Craniofacial Research

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Comprehensive molecular profiling of lung adenocarcinoma;Cancer Genome Atlas Research Network;Nature,2014

2. KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma;Gao;Lung Cancer,2020

3. A Comparative analysis of individual RAS mutations in cancer biology;Muñoz-Maldonado;Front. Oncol.,2019

4. KRAS-specific amino acid substitutions are associated with different responses to chemotherapy in advanced non-small-cell lung cancer;Renaud;Clin. Lung Cancer.,2018

5. KRAS-Driven lung adenocarcinoma and B cell infiltration: novel insights for immunotherapy;Rosamaria;Cancers,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis;Mathematical Biosciences;2023-12

2. Mutation bias and the predictability of evolution;Philosophical Transactions of the Royal Society B: Biological Sciences;2023-04-03

3. Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development—a narrative review;Translational Lung Cancer Research;2023-02